Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
6.38
-0.31 (-4.63%)
At close: Jan 23, 2026, 4:00 PM EST
6.40
+0.02 (0.32%)
After-hours: Jan 23, 2026, 7:10 PM EST
Verastem Market Cap
Verastem has a market cap or net worth of $492.42 million as of January 23, 2026. Its market cap has increased by 69.16% in one year.
Market Cap
492.42M
Enterprise Value
444.19M
1-Year Change
69.16%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $492.42M, an increase of 130.86%. That is a compound annual growth rate of 6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 426.00M | -17.36% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
| Jan 27, 2012 | 213.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 556.60M |
| Lyell Immunopharma | 548.94M |
| Ocugen | 541.02M |
| Solid Biosciences | 534.46M |
| Alto Neuroscience | 533.72M |
| Zevra Therapeutics | 511.18M |
| Niagen Bioscience | 502.96M |
| Bicycle Therapeutics | 500.84M |